{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:34:05Z","timestamp":1791326045911,"version":"4.3.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s10620-021-06833-6","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T02:11:44Z","timestamp":1612318304000},"page":"177-186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Acceptability and Adequacy of a Non-endoscopic Cell Collection Device for Diagnosis of Barrett\u2019s Esophagus: Lessons Learned"],"prefix":"10.1007","volume":"67","author":[{"given":"Nicholas J.","family":"Shaheen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinadh","family":"Komanduri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Raman","family":"Muthusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Wani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"O\u2019Donovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajinder","family":"Kaushal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Haydek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,3]]},"reference":[{"issue":"6","key":"6833_CR1","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1158\/1055-9965.EPI-10-0012","volume":"19","author":"H Pohl","year":"2010","unstructured":"Pohl H, Sirovich B, Welch HG. Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol Biomarkers Prev. 2010;19:1468\u20131470","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"8","key":"6833_CR2","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1007\/s10620-018-5068-6","volume":"63","author":"AP Thrift","year":"2018","unstructured":"Thrift AP. Barrett\u2019s esophagus and esophageal adenocarcinoma: how common are they really? Dig Dis Sci. 2018;63:1988\u20131996. https:\/\/doi.org\/10.1007\/s10620-018-5068-6.","journal-title":"Dig Dis Sci."},{"issue":"7","key":"6833_CR3","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1111\/j.1572-0241.2003.07454.x","volume":"98","author":"MA Eloubeidi","year":"2003","unstructured":"Eloubeidi MA, Mason AC, Desmond RA, El-Serag HB. Temporal trends (1973\u20131997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? Am J Gastroenterol. 2003;98:1627\u20131633. https:\/\/doi.org\/10.1111\/j.1572-0241.2003.07454.x.","journal-title":"Am J Gastroenterol."},{"issue":"1","key":"6833_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/ajg.2015.322","volume":"111","author":"NJ Shaheen","year":"2016","unstructured":"Shaheen NJ, Falk GW, Iyer PG, Gerson LB. American College of G ACG clinical guideline: diagnosis and management of Barrett\u2019s Esophagus. Am J Gastroenterol. 2016;111:30\u201350. https:\/\/doi.org\/10.1038\/ajg.2015.322.","journal-title":"Am J Gastroenterol."},{"issue":"3","key":"6833_CR5","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1053\/j.gastro.2011.01.031","volume":"140","author":"SJ Spechler","year":"2011","unstructured":"Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American Gastroenterological Association medical position statement on the management of Barrett\u2019s esophagus. Gastroenterology. 2011;140:1084\u20131091","journal-title":"Gastroenterology."},{"issue":"1","key":"6833_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/gutjnl-2013-305372","volume":"63","author":"RC Fitzgerald","year":"2014","unstructured":"Fitzgerald RC, di Pietro M, Ragunath K et al. British society of gastroenterology guidelines on the diagnosis and management of Barrett\u2019s oesophagus. Gut. 2014;63:7\u201342. https:\/\/doi.org\/10.1136\/gutjnl-2013-305372.","journal-title":"Gut."},{"issue":"12","key":"6833_CR7","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1001\/jama.2014.2511","volume":"311","author":"KN Phoa","year":"2014","unstructured":"Phoa KN, van Vilsteren FGI, Weusten BLAM et al. Radiofrequency ablation vs endoscopic surveillance for patients with barrett esophagus and low-grade dysplasia a randomized clinical trial. Jama-J Am Med Assoc. 2014;311:1209\u20131217. https:\/\/doi.org\/10.1001\/jama.2014.2511.","journal-title":"Jama-J Am Med Assoc."},{"issue":"22","key":"6833_CR8","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMoa0808145","volume":"360","author":"NJ Shaheen","year":"2009","unstructured":"Shaheen NJ, Sharma P, Overholt BF et al. Radiofrequency ablation in Barrett\u2019s esophagus with dysplasia. N Engl J Med. 2009;360:2277\u20132288. https:\/\/doi.org\/10.1056\/NEJMoa0808145.","journal-title":"N Engl J Med."},{"issue":"6","key":"6833_CR9","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/j.1572-0241.2002.05767.x","volume":"97","author":"NJ Shaheen","year":"2002","unstructured":"Shaheen NJ, Provenzale D, Sandler RS. Upper endoscopy as a screening and surveillance tool in esophageal adenocarcinoma: a review of the evidence. Am J Gastroenterol. 2002;97:1319\u20131327. https:\/\/doi.org\/10.1111\/j.1572-0241.2002.05767.x.","journal-title":"Am J Gastroenterol."},{"issue":"4","key":"6833_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nrgastro.2015.24","volume":"12","author":"TL Vaughan","year":"2015","unstructured":"Vaughan TL, Fitzgerald RC. Precision prevention of oesophageal adenocarcinoma. Nat Rev Gastroenterol Hepatol. 2015;12:243\u2013248. https:\/\/doi.org\/10.1038\/nrgastro.2015.24.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"6833_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2019.04.250","author":"S Wani","year":"2019","unstructured":"Wani S, Williams JL, Komanduri S, Muthusamy VR, Shaheen NJ. Endoscopists systematically undersample patients with long-segment Barrett\u2019s esophagus: an analysis of biopsy sampling practices from a quality improvement registry. Gastrointest Endosc. 2019. https:\/\/doi.org\/10.1016\/j.gie.2019.04.250.","journal-title":"Gastrointest Endosc."},{"issue":"7","key":"6833_CR12","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.cgh.2008.12.027","volume":"7","author":"JA Abrams","year":"2009","unstructured":"Abrams JA, Kapel RC, Lindberg GM et al. Adherence to biopsy guidelines for Barrett\u2019s esophagus surveillance in the community setting in the United States. Clin Gastroenterol Hepatol. 2009;7:736\u2013742","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"4","key":"6833_CR13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1053\/hupa.2001.23510","volume":"32","author":"E Montgomery","year":"2001","unstructured":"Montgomery E, Bronner MP, Goldblum JR et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol. 2001;32:368\u2013378","journal-title":"Hum Pathol."},{"issue":"5","key":"6833_CR14","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1136\/gut.51.5.671","volume":"51","author":"AH Ormsby","year":"2002","unstructured":"Ormsby AH, Petras RE, Henricks WH et al. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut. 2002;51:671\u2013676","journal-title":"Gut."},{"issue":"2","key":"6833_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00428-015-1878-5","volume":"468","author":"L Mastracci","year":"2016","unstructured":"Mastracci L, Piol N, Molinaro L et al. Interobserver reproducibility in pathologist interpretation of columnar-lined esophagus. Virchows Arch. 2016;468:159\u2013167. https:\/\/doi.org\/10.1007\/s00428-015-1878-5.","journal-title":"Virchows Arch."},{"issue":"1","key":"6833_CR16","doi-asserted-by":"publisher","first-page":"e1001780","DOI":"10.1371\/journal.pmed.1001780","volume":"12","author":"CS Ross-Innes","year":"2015","unstructured":"Ross-Innes CS, Debiram-Beecham I, O\u2019Donovan M et al. Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression for diagnosing Barrett\u2019s esophagus: a multi-center case-control study. PLoS Med. 2015;12:e1001780. https:\/\/doi.org\/10.1371\/journal.pmed.1001780.","journal-title":"PLoS Med."},{"key":"6833_CR17","doi-asserted-by":"publisher","first-page":"c4372","DOI":"10.1136\/bmj.c4372","volume":"341","author":"SR Kadri","year":"2010","unstructured":"Kadri SR, Lao-Sirieix P, O\u2019Donovan M et al. Acceptability and accuracy of a non-endoscopic screening test for Barrett\u2019s oesophagus in primary care: cohort study. BMJ. 2010;341:c4372. https:\/\/doi.org\/10.1136\/bmj.c4372.","journal-title":"BMJ."},{"issue":"11","key":"6833_CR18","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1136\/gut.2009.180281","volume":"58","author":"P Lao-Sirieix","year":"2009","unstructured":"Lao-Sirieix P, Boussioutas A, Kadri SR et al. Non-endoscopic screening biomarkers for Barrett\u2019s oesophagus: from microarray analysis to the clinic. Gut. 2009;58:1451\u20131459. https:\/\/doi.org\/10.1136\/gut.2009.180281.","journal-title":"Gut."},{"issue":"4","key":"6833_CR19","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.cgh.2018.07.043","volume":"17","author":"W Januszewicz","year":"2019","unstructured":"Januszewicz W, Tan WK, Lehovsky K et al. Safety and Acceptability of Esophageal Cytosponge Cell Collection Device in a Pooled Analysis of Data From Individual Patients. Clin Gastroenterol Hepatol 2019;17:647\u2013656. https:\/\/doi.org\/10.1016\/j.cgh.2018.07.043.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10247","key":"6833_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/s0140-6736(20)31099-0","volume":"396","author":"RC Fitzgerald","year":"2020","unstructured":"Fitzgerald RC, di Pietro M, O\u2019Donovan M et al. Cytosponge-trefoil factor 3 versus usual care to identify Barrett\u2019s oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial. Lancet. 2020;396:333\u2013344. https:\/\/doi.org\/10.1016\/s0140-6736(20)31099-0.","journal-title":"Lancet."},{"issue":"11","key":"6833_CR21","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1097\/MEG.0000000000001210","volume":"30","author":"U Iqbal","year":"2018","unstructured":"Iqbal U, Siddique O, Ovalle A, Anwar H, Moss SF. Safety and efficacy of a minimally invasive cell sampling device ('Cytosponge\u2019) in the diagnosis of esophageal pathology: a systematic review. Eur J Gastroenterol Hepatol. 2018;30:1261\u20131269. https:\/\/doi.org\/10.1097\/MEG.0000000000001210.","journal-title":"Eur J Gastroenterol Hepatol."},{"issue":"5","key":"6833_CR22","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1053\/j.gastro.2012.08.002","volume":"143","author":"AF Peery","year":"2012","unstructured":"Peery AF, Dellon ES, Lund J et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology 2012;143:1179\u20131187","journal-title":"Gastroenterology"},{"issue":"1","key":"6833_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S2468-1253(16)30118-2","volume":"2","author":"CS Ross-Innes","year":"2017","unstructured":"Ross-Innes CS, Chettouh H, Achilleos A et al. Risk stratification of Barrett\u2019s oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study. Lancet Gastroenterol Hepatol. 2017;2:23\u201331. https:\/\/doi.org\/10.1016\/S2468-1253(16)30118-2.","journal-title":"Lancet Gastroenterol Hepatol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-06833-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-021-06833-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-06833-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T19:45:53Z","timestamp":1641584753000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-021-06833-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,3]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["6833"],"URL":"https:\/\/doi.org\/10.1007\/s10620-021-06833-6","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,3]]},"assertion":[{"value":"27 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Nicholas J. Shaheen has served as a consultant for Cernostics, Lucid, and Cook Medical, and has received research funding from Medical, C2 Therapeutics, Medtronic, Interpace Diagnostics, CDx Medical, EndoStim and Ironwood Pharmaceuticals. Maria O\u2019Donovan has served as a consultant for Medtronic plc. She is named on patents relating to the original Cytosponge design and TFF3 assay licensed to Medtronic. She is a cofounder of Cyted Ltd. V. Raman Muthusamy has served as a consultant for Boston Scientific, Interpace Diagnostics, Medtronic, and Torax Medical (Ethicon), and has received research funding from Boston Scientific and Medtronic. Sachin Wani has served as a consultant for Boston Scientific, Medtronic, Interpace Diagnostics and Cernostics.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}